Goldman Sachs’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $158K | Buy |
|
|||||
|
2025
Q2 | $72.8K | Sell |
|
|||||
|
2025
Q1 | $875K | Buy |
|
|||||
|
2024
Q4 | $597K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $76K | Buy |
|
|||||
|
2017
Q1 | $13K | Sell |
|
|||||
|
2016
Q4 | $61K | Buy |
|
|||||
|
2016
Q3 | $33K | Sell |
|
|||||
|
2016
Q2 | $143K | Buy |
|
|||||
|
2016
Q1 | $109K | Buy |
|
|||||
|
2015
Q4 | $146K | Buy |
|
|||||
|
2015
Q3 | $128K | Buy |
|
|||||
|
2015
Q2 | $162K | Sell |
|
|||||
|
2015
Q1 | $169K | Sell |
|
|||||
|
2014
Q4 | $530K | Buy |
|